Skip to main content
European Journal of Microbiology & Immunology logoLink to European Journal of Microbiology & Immunology
. 2014 Mar 14;4(1):83–87. doi: 10.1556/EuJMI.4.2014.1.8

Congenital IL-12R1β receptor deficiency and thrombophilia in a girl homozygous for an IL12RB1 mutation and compound heterozygous for MTFHR mutations: A case report and literature review

H H Akar 1,1,*, M Kose 2,2, O Ceylan 3,3, T Patiroglu 4,1, J Bustamante 5,6,4,5, J L Casanova 7,8,4,6, B N Akyildiz 9,7, S Doganay 10,8
PMCID: PMC3955835  PMID: 24678409

Abstract

Interleukin-12 (IL-12) plays an important role in the production of interferon gamma from T cells and natural killer cells and is essential for protection against intra-macrophagic pathogens such as Mycobacterium and Salmonella. Here, we describe a 16-year-old girl with homozygous mutation in exon 12 of the IL12RB1 gene, which causes complete IL-12Rβ1 deficiency in association with heterozygous mutation (C677T and A1298C) in the methylenetetrahydrofolate reductase gene. She presented with disseminated Mycobacterium tuberculosis complex infection, retroperitoneal fungal abscess and also thrombosis in the superior mesenteric–portal vein junction. This is the first case report of a primary immunodeficiency associated with a genetically determined venous thrombosis.

Keywords: IL-12Rβ1 receptor deficiency, methylenetetrahydrofolatereductase, retroperitoneal fungal abscess, superior mesenteric–portal vein junction thrombosis, thrombophilia

Introduction

Cell-mediated immunity, in which interaction between T lymphocytes and macrophages is fundamental, is crucial for host defense against intracellular pathogens such as Mycobacterium and Salmonella species. In this setting the most important step is activation of macrophages by type 1 cytokines, in particular interferon (IFN)-γ [1]. The human molecular genetic dissection of pediatric tuberculosis (TB) was facilitated from 1996 onward by the dissection of genetic etiologies of the syndrome of Mendelian susceptibility to mycobacterial disease (MSMD), which is characterized by clinical disease caused by weakly virulent mycobacteria, such as BCG-vaccines and environmental mycobacteria (EM; also known as atypical or non-tuberculous mycobacteria), in otherwise healthy children who are normally resistant to most other infectious agents. These patients are also susceptible to Mycobacterium tuberculosis (Mtb) [23, 5]. The study of patients with MSMD has demonstrated the key role of the IL-12/IFN-γ axis in immunity to mycobacteria in humans [4, 6]. There are as many as 17 genetic etiologies of MSMD. They involve nine genes controlling IFN-γ immunity [5, 6, 9]. The most common etiology is autosomal recessive IL-12Rβ1 deficiency, which represents approximately 40% of all MSMD cases [3, 7]. Here, we describe the first case of IL-12Rβ1 deficiency in a girl who also has thrombosis in superior mesenteric and portal vein junction associated with heterozygous mutation (C677T and A1298C) in the methylenetetrahydrofolate reductase (MTHFR) gene.

Case report

A 16-year-old girl is the first child of healthy parents who are second-degree cousins in Turkey. All three siblings (including the patient) were vaccinated with Bacillus Calmette–Guerin (BCG), with no overt adverse effect in the following months. One brother is healthy at 11 years of age. The second brother with a history of pulmonary TB is 5 years old. The patient’s parents and oldest brother had negative tuberculin skin test results. The patient’s illness began when she was two years old with fever, weakness and a cervical mass with purulent discharge. She had axillary, retroauricular and inguinal lymphadenopathies. She was treated with antituberculosis (anti-TB) drugs four times for tuberculosis lymphadenitis (3 times cervical and 1 axillary). The first anti-TB treatment (isoniazid, pyrazinamide, and rifampicin) was given when she was 10 years old. At the age of 14, she was being treated again with anti-TB drugs (isoniazid, pyrazinamide, and rifampicin) for 6 months in another university hospital. This treatment went on for 6 months. She also experienced retroperitoneal abscess in those years. The etiology was found to be non-typhoidal Salmonella from abscess culture. After 6 months of anti-TB treatment, she was admitted to the hospital with productive cough, weakness, fatigue, abdominal pain, and night sweat. Physical examination revealed an anterior cervical 4×3 cm mass with pain and fluctuation, crackles on examination of the respiratory system, and infiltration on chest X-ray. Her weight was below the third percentile but her height was normal. At that time, laboratory test results were normal for counter blood cell (CBC), immunoglobulins (A, G, M, E and subgroub G), lymphocyte subsets and phagotest. Mycobacterium tuberculosis complex (MTBC) was cultured from the drained material of cervical mass with BACTEC automated system. Acid-fast bacilli were detected from gastric lavage of the fasting stomach in the morning. Also, acid-fast bacilli were seen in the drained material. Whole blood samples were in vitro activated with BCG, BCG plus IL-12 and BCG plus IFN-γ as described previously [4]. IL-12p40 production was increased after stimulation with BCG plus IFN-γ. In contrast, IFN-γ production in response to BCG plus IL-12 was blunted. Mutation analysis revealed a homozygous mutation, R486X, in exon 12 of IL12RB1. Biological materials were not available for parents and siblings. After this medical history, physical examination, positive laboratory findings, quartet anti-TB treatment (isoniazid, pyrazinamide, rifampicin, and ethambutol) were resumed. The patient with this treatment was being followed. The patient did not come to policlinic control for almost one year. At the age of 16, the patient was admitted to the pediatric emergency department with fever, productive cough, abdominal pain, headache, blurred vision, weakness, fatigue, and night sweats. Hepatosplenomegaly, superior mesenteric–portal vein junction thrombosis, and plenty of collateral veins were demonstrated with the ultrasonography of abdomen. The computerized abdominal tomography (CT) showed 4.5×3.5 cm retroperitoneal abscess (Fig. 1) and multiple lymphadenopathies in addition of ultrasound. The thrombosis was evaluated chronically. The patient was found to be compound heterozygous for the MTFHR gene both in C677T and A1298C alleles. Homocysteine, vitamin B12 and folate levels were normal. Enoxaparin was given to the patient for thrombosis. Retroperitoneal abscess was drained by interventional radiologist. Candida albicans was cultured from drained material. Fluconazole was added to the patient’s treatment. Cranial magnetic resonance imaging (MRI) showed focal nodular enhancing lesion in right posterolateral zone of pons (tuberculosis granuloma?) (Fig. 2) and irregularity and thickening with pathological contrast enhancement in the left middle cerebral artery wall probably due to vascular involvement of TB (Fig. 3). Bilateral pupil edema was seen on fundoscopic examination. Methylprednisolone was started to the patient. Mycobacterium tuberculosis Polymerase Chain Reaction (PCR) was found to be positive in the cerebrospinal fluid. Also MTBC was grown in cerebrospinal fluid culture. Second month in the hospitalization, repeated cranial MRI showed enhancement and thickening of basal cisterns consistent with TB meningitis (Fig. 4) and again thickening and enhancement of left middle cerebral artery consistent with TB vasculitis and left thalamic lacunar infarction. The patient experienced sudden unconsciousness at the third month in hospitalization. Cranial MRI revealed acute infarction in both cerebral hemispheres. The patient was interned to the pediatric intensive care unit. The patient died almost four months after the hospitalization in pediatric intensive care unit.

Fig. 1.

Fig. 1.

Axial CT image shows right retroperitoneal abscess (long arrow), chronic trombosis in the main portal vein (thick arrow) and cavenous transformation (short arrow)

Fig. 2.

Fig. 2.

Axial T1-weighted MR image shows nodular enhancement (tuberculoma) in the right pons (arrow)

Fig. 3.

Fig. 3.

Axial T1-weighted MR image shows thickening and enhancement in the left middle cerebral artery wall (arrow)

Fig. 4.

Fig. 4.

Axial T1-weighted MR image shows pathologic thickening and enhancement of basal cisterns (arrow)

Discussion

Here, we report a 16-year-old girl with disseminated MTBC and superior mesenteric–portal venous junction thrombosis. The diagnosis was based on both clinical and genetic features. In our patient, MTBC was cultured from cerebrospinal fluid and drained cervical mass. C. albicans was cultured from retroperitoneal abscess material. Non-typhoidal Salmonella was cultured in retroperitoneal abscess. These three microbes, M. tuberculosis, Salmonella and C. albicans have been reported in patients with MSMD, including in particular patients with IL-12Rβ1 and IL-12p40 deficiencies [810]. She had a complete IL-12Rβ1 deficiency caused by a homozygous mutation in the IL12RB1. IL-12 and IL-23 are produced by macrophages and dendritic cells, binding to their receptors consisting of IL-12Rβ1 and IL-12Rβ2 that are expressed on natural killer cells and T lymphocytes. This stimulation causes IFN-γ production. IFN-γ binds to IFN-γ receptor and leads to phosphorylation of a signal transducer and activator of transcription type 1 (STAT-1). Defects in any pathway of the IL-12/IFN-γ axis cause susceptibility to mycobacteria or other infectious pathogens in humans [7, 8]. Impaired IL-23-dependent expansion of IL-17 T cells also probably account for candidiasis in such patients [1113].

Another clinical manifestation in this patient was superior mesenteric–portal venous junction thrombosis, probably due to constitutive thrombophilia. To our knowledge, this clinical manifestation was never reported in IL-12Rβ1 deficiency. Congenital thrombophilia includes deficiencies of antithrombin III, protein C and protein S, and the factor V Leiden mutation, the prothrombin gene variant and bi-allelic mutations in the MTHFR [14]. Congenital thrombophilias are responsible from almost 35% percent of the etiology of intraabdominal vein thrombosis events [15]. Splenic and mesenteric venous thrombosis in an adult, who has compound heterozygous for the MTFHR C677T and A1298C alleles, was reported by Gürsoy et al. [16] from Turkey. Also, Jurcuţ et al. [17] reported a patient with recurrent deep thrombosis related to hyperhomocysteinemia, and compound heterozygosity for the C677T and A1298C mutations. A study suggested that mutations in MTHFR gene for allele C677T and A1298C have a tendency to associate with coronary artery disease, in both homozygous and heterozygous carriers even when blood homocysteine levels were not elevated [18]. The patient reported here, whose homocysteine level was not elevated, was heterozygous for both C677T and A1298C alleles of MTHFR gene.

In conclusion, the present case report neatly emphasizes the importance of considering multiple genetic disorders in individual patients with a complex phenotype. Ehlayel et al. [19] had previously reported the occurrence of IL-12Rβ1 deficiency and Ataxia-Telangiectasia. Another group had also reported Wiskott–Aldrich syndrome in a family with Fanconi anemia [20]. Congenital thrombophilia should be considered in immunodeficient patients with unexplained idiopathic venous thrombosis, as illustrated in the patient reported here, who suffered from both IL-12Rβ1 deficiency and thrombophilia.

Footnotes

Conflict of interest. The authors declare that they have no conflict of interest.

Contributor Information

H. H. Akar, 1Department of Pediatric Immunology, Medical Faculty, Erciyes University, Kayseri, Turkey.

M. Kose, 2Department of Pediatric Pulmonology, Medical Faculty, Erciyes University, Kayseri, Turkey.

O. Ceylan, 3Department of Pediatric Infectious Diseases, Medical Faculty, Erciyes University, Kayseri, Turkey.

T. Patiroglu, 1Department of Pediatric Immunology, Medical Faculty, Erciyes University, Kayseri, Turkey.

J. Bustamante, 4Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale, U980, University Paris Descartes, Necker Medical School, Foundation Imagine, Paris, France; 5Center for Study of Primary Immunodeficiencies, AP-HP, Necker Hospital, Paris, France.

J. L. Casanova, 4Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale, U980, University Paris Descartes, Necker Medical School, Foundation Imagine, Paris, France; 6St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.

B. N. Akyildiz, 7Department of Pediatric Intensive Care Unit, Medical Faculty, Erciyes University, Kayseri, Turkey.

S. Doganay, 8Department of Pediatric Radiology, Medical Faculty, Erciyes University, Kayseri, Turkey.

References

  • 1.Rosenzweig SD, Holland SM. White blood cell defects. In: Leung DYM, Sampson HA, Geha RS, Szefler SJ, editors. Pediatric Allergy Principles and Practice. St Louis, MI: Mosby; 2003. pp. 130–144. [Google Scholar]
  • 2.Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol. 2002;20:581–620. doi: 10.1146/annurev.immunol.20.081501.125851. [DOI] [PubMed] [Google Scholar]
  • 3.Filipe-Santos O, Bustamante J, Chapgier A, Vogt G, de Beaucoudrey L, Feinberg J, Jouanguy E, Boisson-Dupuis S, Fieschi C, Picard C, Casanova JL. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol. 2006 Dec;18(6):347–361. doi: 10.1016/j.smim.2006.07.010. [DOI] [PubMed] [Google Scholar]
  • 4.Feinberg J, Fieschi C, Doffinger R, Feinberg M, Leclerc T, Boisson-Dupuis S, Picard C, Bustamante J, Chapgier A, Filipe-Santos O, Ku CL, de Beaucoudrey L, Reichenbach J, Antoni G, Baldé R, Alcaïs A, Casanova JL. Bacillus Calmette Guerin triggers the IL-12/IFN-gamma axis by an IRAK-4- and NEMO-dependent, non-cognate interaction between monocytes, NK, and T lymphocytes. Eur J Immunol. 2004 Nov;34(11):3276–3284. doi: 10.1002/eji.200425221. [DOI] [PubMed] [Google Scholar]
  • 5.Boisson-Dupuis S, El Baghdadi J, Parvaneh N, Bousfiha A, Bustamante J, Feinberg J, Samarina A, Grant AV, Janniere L, El Hafidi N, Hassani A, Nolan D, Najib J, Camcioglu Y, Hatipoglu N, Aydogmus C, Tanir G, Aytekin C, Keser M, Somer A, Aksu G, Kutukculer N, Mansouri D, Mahdaviani A, Mamishi S, Alcais A, Abel L, Casanova JL. IL-12Rβ1 deficiency in two of fifty children with severe tuberculosis from Iran, Morocco, and Turkey. PLoS One. 2011 Apr 13;6(4):e18524. doi: 10.1371/journal.pone.0018524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Bustamante J, Picard C, Boisson-Dupuis S, Abel L, Casanova JL. Genetic lessons learned from X-linked Mendelian susceptibility to mycobacterial diseases. Ann N Y Acad Sci. 2011 Dec;1246:92–101. doi: 10.1111/j.1749-6632.2011.06273.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Tanir G, Dogu F, Tuygun N, Ikinciogullari A, Aytekin C, Aydemir C, Yuksek M, Boduroglu EC, de Beaucoudrey L, Fieschi C, Feinberg J, Casanova JL, Babacan E. Complete deficiency of the IL-12 receptor beta1 chain: three unrelated Turkish children with unusual clinical features. Eur J Pediatr. 2006 Jun;165(6):415–417. doi: 10.1007/s00431-005-0078-8. [DOI] [PubMed] [Google Scholar]
  • 8.de Beaucoudrey L, Samarina A, Bustamante J, Cobat A, Boisson-Dupuis S, Feinberg J, Al-Muhsen S, Jannière L, Rose Y, de Suremain M, Kong XF, Filipe-Santos O, Chapgier A, Picard C, Fischer A, Dogu F, Ikinciogullari A, Tanir G, Al-Hajjar S, Al-Jumaah S, Frayha HH, AlSum Z, Al-Ajaji S, Alangari A, Al-Ghonaium A, Adimi P, Mansouri D, Ben-Mustapha I, Yancoski J, Garty BZ, Rodriguez-Gallego C, Caragol I, Kutukculer N, Kumararatne DS, Patel S, Doffinger R, Exley A, Jeppsson O, Reichenbach J, Nadal D, Boyko Y, Pietrucha B, Anderson S, Levin M, Schandené L, Schepers K, Efira A, Mascart F, Matsuoka M, Sakai T, Siegrist CA, Frecerova K, Blüetters-Sawatzki R, Bernhöft J, Freihorst J, Baumann U, Richter D, Haerynck F, De Baets F, Novelli V, Lammas D, Vermylen C, Tuerlinckx D, Nieuwhof C, Pac M, Haas WH, Müller-Fleckenstein I, Fleckenstein B, Levy J, Raj R, Cohen AC, Lewis DB, Holland SM, Yang KD, Wang X, Wang X, Jiang L, Yang X, Zhu C, Xie Y, Lee PP, Chan KW, Chen TX, Castro G, Natera I, Codoceo A, King A, Bezrodnik L, Di Giovani D, Gaillard MI, de Moraes-Vasconcelos D, Grumach AS, da Silva Duarte AJ, Aldana R, Espinosa-Rosales FJ, Bejaoui M, Bousfiha AA, Baghdadi JE, Ozbek N, Aksu G, Keser M, Somer A, Hatipoglu N, Aydogmus C, Asilsoy S, Camcioglu Y, Gülle S, Ozgur TT, Ozen M, Oleastro M, Bernasconi A, Mamishi S, Parvaneh N, Rosenzweig S, Barbouche R, Pedraza S, Lau YL, Ehlayel MS, Fieschi C, Abel L, Sanal O, Casanova JL. Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore) 2010 Nov;89(6):381–402. doi: 10.1097/MD.0b013e3181fdd832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Al-Muhsen S, Casanova JL. The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. J Allergy Clin Immunol. 2008 Dec;122(6):1043–51. doi: 10.1016/j.jaci.2008.10.037. [DOI] [PubMed] [Google Scholar]
  • 10.Prando C, Samarina A, Bustamante J, Boisson-Dupuis S, Cobat A, Picard C, AlSum Z, Al-Jumaah S, Al-Hajjar S, Frayha H, Alangari A, Al-Mousa H, Mobaireek KF, Ben-Mustapha I, Adimi P, Feinberg J, de Suremain M, Jannière L, Filipe-Santos O, Mansouri N, Stephan JL, Nallusamy R, Kumararatne DS, Bloorsaz MR, Ben-Ali M, Elloumi-Zghal H, Chemli J, Bouguila J, Bejaoui M, Alaki E, AlFawaz TS, Al Idrissi E, ElGhazali G, Pollard AJ, Murugasu B, Wah Lee B, Halwani R, Al-Zahrani M, Al Shehri MA, Al-Zahrani M, Bin-Hussain I, Mahdaviani SA, Parvaneh N, Abel L, Mansouri D, Barbouche R, Al-Muhsen S, Casanova JL. Inherited IL-12p40 deficiency: genetic, immunologic, and clinical features of 49 patients from 30 kindreds. Medicine (Baltimore) 2013 Mar;92(2):109–122. doi: 10.1097/MD.0b013e31828a01f9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.de Beaucoudrey L, Puel A, Filipe-Santos O, Cobat A, Ghandil P, Chrabieh M, Feinberg J, von Bernuth H, Samarina A, Jannière L, Fieschi C, Stéphan JL, Boileau C, Lyonnet S, Jondeau G, Cormier-Daire V, Le Merrer M, Hoarau C, Lebranchu Y, Lortholary O, Chandesris MO, Tron F, Gambineri E, Bianchi L, Rodriguez-Gallego C, Zitnik SE, Vasconcelos J, Guedes M, Vitor AB, Marodi L, Chapel H, Reid B, Roifman C, Nadal D, Reichenbach J, Caragol I, Garty BZ, Dogu F, Camcioglu Y, Gülle S, Sanal O, Fischer A, Abel L, Stockinger B, Picard C, Casanova JL. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med. 2008 Jul 7;205(7):1543–1550. doi: 10.1084/jem.20080321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, Lim HK, Migaud M, Israel L, Chrabieh M, Audry M, Gumbleton M, Toulon A, Bodemer C, El-Baghdadi J, Whitters M, Paradis T, Brooks J, Collins M, Wolfman NM, Al-Muhsen S, Galicchio M, Abel L, Picard C, Casanova JL. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science. 2011 Apr 1;332(6025):65–68. doi: 10.1126/science.1200439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Puel A, Cypowyj S, Maródi L, Abel L, Picard C, Casanova JL. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr Opin Allergy Clin Immunol. 2012 Dec;12(6):616–622. doi: 10.1097/ACI.0b013e328358cc0b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Verspyck E, Le Cam-Duchez V, Borg JY, Marpeau L. [Inherited thrombophilia and pregnancy] J Gynecol Obstet Biol Reprod (Paris) 2000 May;29(3):227–229. [PubMed] [Google Scholar]
  • 15.Leebeek FW, Smalberg JH, Janssen HL. Prothrombotic disorders in abdominal vein thrombosis. Neth J Med. 2012 Nov;70(9):400–405. [PubMed] [Google Scholar]
  • 16.Gürsoy G, Cimbek A, Acar Y, Erol B, Dal HC, Evrin N, Gungor A. Combined portal, splenic and mesenteric venous thrombosis in inactive ulcerative colitis with heterozygous mutation in MTHFR gene: A rare case of thrombophilia. J Res Med Sci. 2011 Nov;16(11):1500–1506. [PMC free article] [PubMed] [Google Scholar]
  • 17.Jurcuţ R, Pop I, Coriu D, Grasu M, Zilişteanu D, Giuşcă S, Ginghină C. Compound heterozygosity for the C677T and A1298C mutations of the MTHFR gene in a case of hyperhomocysteinemia with recurrent deep thrombosis at young age. Rom J Intern Med. 2008;46(3):255–259. [PubMed] [Google Scholar]
  • 18.Szczeklik A, Sanak M, Jankowski M, Dropiński J, Czachór R, Musiał J, Axenti I, Twardowska M, Brzostek T, Tendera M. Mutation A1298C of methylenetetrahydrofolate reductase: risk for early coronary disease not associated with hyperhomocysteinemia. Am J Med Genet. 2001 Jun 1;101(1):36–39. doi: 10.1002/ajmg.1315. [DOI] [PubMed] [Google Scholar]
  • 19.Ehlayel M, de Beaucoudrey L, Fike F, Nahas SA, Feinberg J, Casanova JL, Gatti RA. Simultaneous presentation of 2 rare hereditary immunodeficiencies: IL-12 receptor beta1 deficiency and ataxia-telangiectasia. J Allergy Clin Immunol. 2008 Dec;122(6):1217–1219. doi: 10.1016/j.jaci.2008.07.005. [DOI] [PubMed] [Google Scholar]
  • 20.Rohrer J, Ribeiro RC, Auerbach AD, Mirro B, Conley ME. Wiskott-Aldrich syndrome in a family with Fanconi anemia. J Pediatr. 1996 Jul;129(1):50–55. doi: 10.1016/s0022-3476(96)70189-0. [DOI] [PubMed] [Google Scholar]

Articles from European Journal of Microbiology & Immunology are provided here courtesy of Akadémiai Kiadó

RESOURCES